Kathleen Swanson

Associate

Overview

Kathleen Swanson is an associate in the firm’s Health Care Group. She focuses her practice on managed care matters, advising clients on a wide range of regulatory issues.

Prior to joining Crowell & Moring, Kathleen served as an attorney-advisor for the U.S. Department of Health and Human Services’ Office of the General Counsel. In this capacity, she advised Centers for Medicare and Medicaid Services teams on matters involving the Inflation Reduction Act (IRA), the Medicare Drug Price Negotiation Program, HIPAA, and data privacy, among other issues.

During law school at the University of Maryland, Kathleen received the CALI Excellence for the Future Award for Torts and Criminal Law. She also served as co-president of the Student Health Law Organization and as notes and comments editor of the Journal of Health Care Law and Policy.

Career & Education

    • University of Maryland School of Law, J.D.,
      cum laude
      , 2020
    • The Ohio State University, B.A., political science, magna cum laude, 2017
    • University of Maryland School of Law, J.D.,
      cum laude
      , 2020
    • The Ohio State University, B.A., political science, magna cum laude, 2017
    • District of Columbia
    • District of Columbia

Kathleen's Insights

Client Alert | 4 min read | 09.26.25

Court Vacates CMS’s 2023 Final Rule on RADV Audits

On September 25, 2025, the Northern District of Texas granted plaintiffs’ motion for summary judgment in Humana v. Becerra, vacating CMS’s 2023 Final Rule regarding risk adjustment data validation (RADV) audits. In the litigation, Humana challenged CMS’s decision in the Final Rule to not continue applying a Fee-for-Service (FFS) adjuster to its RADV audit methodology....

Kathleen's Insights

Client Alert | 4 min read | 09.26.25

Court Vacates CMS’s 2023 Final Rule on RADV Audits

On September 25, 2025, the Northern District of Texas granted plaintiffs’ motion for summary judgment in Humana v. Becerra, vacating CMS’s 2023 Final Rule regarding risk adjustment data validation (RADV) audits. In the litigation, Humana challenged CMS’s decision in the Final Rule to not continue applying a Fee-for-Service (FFS) adjuster to its RADV audit methodology....